DXR Daxor Corporation
$11.47▲ +5.81%
Healthcare
Other
After hours
$11.40▼ -0.61%
Sep 11, 4:04 PM ET
Volume 69.7K
Avg Volume (10D) 27.0K
Key Metrics & Fundamentals
Market Cap
$66.96M
P/E Ratio
6.8
Div Yield
–%
52W Range
8.56 - 14.76
% vs 50 MA
9.80%
% vs 200 MA
2.21%
RSI-14
65.6
MACD Histogram
+0.1200
Beta (1Y vs SPY)
0.09
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
GlobeNewswire · Sep 8, 2026 9:40 PM
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
GlobeNewswire · Sep 1, 2026 12:00 PM
Daxor Launches Blood Testing Lab in Eastern Kansis
MT Newswires · Jul 30, 2026 9:27 AM
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
GlobeNewswire · Jul 30, 2026 2:40 AM
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
GlobeNewswire · Jul 7, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for DXR.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.